scholarly journals Mass spectrometry‐based method for quantification of nimodipine and glutamate in cerebrospinal fluid. Pilot study with patients after aneurysmal subarachnoid haemorrhage

2019 ◽  
Vol 45 (1) ◽  
pp. 81-87
Author(s):  
Sonani Mindt ◽  
Ursala Tokhi ◽  
Maren Hedtke ◽  
Hans‐Jürgen Groß ◽  
Daniel Hänggi
Keyword(s):  
Mass Spectrometry ◽  
Cerebrospinal Fluid ◽  
Pilot Study ◽  
Subarachnoid Haemorrhage ◽  
Aneurysmal Subarachnoid Haemorrhage

Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition1H NMR study

2005 ◽  
Vol 18 (1) ◽  
pp. 24-33 ◽  
Author(s):  
Victoria G. Dunne ◽  
Shermina Bhattachayya ◽  
Michael Besser ◽  
Caroline Rae ◽  
Julian L. Griffin
Keyword(s):  
Cerebrospinal Fluid ◽  
Clinical Outcome ◽  
Subarachnoid Haemorrhage ◽  
Aneurysmal Subarachnoid Haemorrhage ◽  
Nmr Study

Superoxide dismutase activity in cisternal cerebrospinal fluid after aneurysmal subarachnoid haemorrhage

1997 ◽  
Vol 139 (11) ◽  
pp. 1033-1037 ◽  
Author(s):  
P. Gaetani ◽  
C. Cafe ◽  
R. Rodriguez y Baena ◽  
F. Tancioni ◽  
C. Torri ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Superoxide Dismutase ◽  
Subarachnoid Haemorrhage ◽  
Superoxide Dismutase Activity ◽  
Aneurysmal Subarachnoid Haemorrhage

Mass spectrometry analysis of redox forms of High-Mobility Group Box-1 Protein in cerebrospinal fluid: initial experience.

2019 ◽  
Vol 88 (3) ◽  
pp. 171-176
Author(s):  
Agata Światły ◽  
Norbert Wąsik ◽  
Joanna Hajduk ◽  
Eliza Matuszewska ◽  
Paweł Dereziński ◽  
...  
Keyword(s):  
Mass Spectrometry ◽  
Cerebrospinal Fluid ◽  
Subarachnoid Hemorrhage ◽  
High Mobility ◽  
High Mobility Group ◽  
Mass Spectrometry Analysis ◽  
Aneurysmal Subarachnoid Haemorrhage ◽  
Top Down ◽  
Spectrometry Analysis ◽  
Redox Forms

Introduction. High-mobility group box 1 (HMGB1) is an alarmin with proinflammatory potential determined by redox status of the cysteines at position 23 and 45. It may also play a role as a biomarker in biological fluids. The aim of this study was the identification of different HMGB1 redox forms in cerebrospinal fluid (CSF) obtained from subarachnoid hemorrhage patients. Material and Methods. 6 CSF samples were collected from aneurysmal subarachnoid haemorrhage patients. Commercially available HMGB1 isoforms served as a positive control. Immunoprecipitation and electrophoretic isolation of HMGB1 protein were performed, then both CSF and control were analyzed using mass spectrometry technique. To distinguish between fully reduced (thiol group at C23 and C45) and disulfide (disulfide bond connecting C23 and C45) HMGB1 forms, top-down sequencing of the spectra was performed. Results. Top-down sequencing analysis allowed to distinguish between HMGB1 isoforms only in commercially available standard without preceding immunoprecipitation and electrophoresis. MALDI spectra differ i.e. on the fully reduced HMGB1 spectrum fragmentation occurs before and beyond C22, which is not present on the disulfide HMGB1 spectrum. Analysis of HMGB1 isolated from CSF obtained from subarachnoid hemorrhage patients gave no results. Conclusions. Top-down sequencing enables to distinguish between redox forms of HMGB1. Electrophoresis and tryptic digestion cannot precede mass spectrometry analysis of redox forms of HMGB1 due to the reduction of disulfide bonds during these processes. Preferred method of isolation of HMGB1 for direct analysis using top-down sequencing mustn’t include protein digestion or degradation.

scholarly journals Correction: Soluble Toll-Like Receptors 2 and 4 in Cerebrospinal Fluid of Patients with Acute Hydrocephalus following Aneurysmal Subarachnoid Haemorrhage

PLoS ONE ◽  
2016 ◽  
Vol 11 (6) ◽  
pp. e0157853
Author(s):  
Bartosz Sokół ◽  
Norbert Wąsik ◽  
Roman Jankowski ◽  
Marcin Hołysz ◽  
Barbara Więckowska ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Subarachnoid Haemorrhage ◽  
Aneurysmal Subarachnoid Haemorrhage ◽  
Toll Like Receptors ◽  
Acute Hydrocephalus

scholarly journals Increase of Soluble RAGE in Cerebrospinal Fluid following Subarachnoid Haemorrhage

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Bartosz Sokół ◽  
Norbert Wąsik ◽  
Roman Jankowski ◽  
Marcin Hołysz ◽  
Witold Mańko ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Subarachnoid Haemorrhage ◽  
Control Group ◽  
Aneurysmal Subarachnoid Haemorrhage ◽  
Pronounced Difference ◽  
Significance Threshold ◽  
Soluble Rage ◽  
Inflammatory Mechanism ◽  
Glycation End Products ◽  
Csf Levels

Receptors for advanced glycation end-products (RAGE) mediate the inflammatory reaction that follows aneurysmal subarachnoid haemorrhage. Soluble RAGE (sRAGE) may function as a decoy receptor. The significance of this endogenous anti-inflammatory mechanism in subarachnoid haemorrhage (SAH) remains unknown. The present study aims to analyse sRAGE levels in the cerebrospinal fluid (CSF) of SAH patients. sRAGE levels were assayed by ELISA kit in 47 CSF samples collected on post-SAH days 0–3, 5–7, and 10–14 from 27 SAH patients with acute hydrocephalus. CSF levels of sRAGE were compared with a control group and correlated with other monitored parameters. In the control group, the CSF contained only a trace amount of sRAGE. By contrast, the CSF of 20 SAH patients collected on post-SAH days 0–3 was found to contain statistically significant higher levels of sRAGE (mean concentration 3.91 pg/mL, p<0.001). The most pronounced difference in CSF sRAGE levels between good and poor outcome patients was found on days 0–3 post-SAH but did not reach the significance threshold (p=0.234). CSF sRAGE levels did not change significantly during hospitalisation (p=0.868) and correlated poorly with treatment outcome, systemic inflammatory markers, and other monitored parameters. Our study revealed an early and constant increase of sRAGE level in the CSF of SAH patients.

Sign in / Sign up

Export Citation Format

Share Document